Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicines For Europe Responds To New EU Biotech Initiative

The Group Calls For Investment That Will Grow European Know-How

Executive Summary

The European off-patent drug organization offered a few suggestions to the European Commission’s unveiled Biotech initiative and its key steps that want to improve the region’s biotech sector.

You may also be interested in...



‘Imperfect Compromise’ On EU Pharma Legislation Still Offers Progress

Reacting to the latest position on the EU pharma legislation overhaul adopted by a European Parliament committee – including changes to previous proposals on regulatory data protection – Medicines for Europe said that the “imperfect” compromise nevertheless offers improvements.

‘We Need To Act Now’: Medicines For Europe On Procurement Policies

The European off-patent drug organization provided several recommendations for medicines procurement to minimize the current focus on lowest-price tenders that are harming competition in the region.

New EU AI Innovation Package Launched, With AI Office

The EU’s AI innovation package offers funding, training and bespoke initiatives to support AI start-ups and SMEs. The Artificial Intelligence Office has been introduced as part of the package.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

GB153401

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel